Working… Menu

Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer Patients (PACT-ACT-v6)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02707159
Recruitment Status : Unknown
Verified March 2016 by Helse Stavanger HF.
Recruitment status was:  Recruiting
First Posted : March 14, 2016
Last Update Posted : March 14, 2016
Information provided by (Responsible Party):
Helse Stavanger HF

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2017
Estimated Study Completion Date : January 2018